In utero lipid nanoparticle delivery achieves robust editing in hematopoietic stem cells.

Saved in:
Bibliographic Details
Title: In utero lipid nanoparticle delivery achieves robust editing in hematopoietic stem cells.
Authors: Worthington AK; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Borges B; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Lum T; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Echeverri ES; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, 30332, USA., Zada FM; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Cordero MA; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Kim H; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, 30332, USA., Zenhausern R; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, 30332, USA., Celik O; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, 30332, USA., Shaw C; Intellia Therapeutics, Cambridge, MA., Gutierrez-Martinez P; Intellia Therapeutics, Cambridge, MA., Omarova M; Intellia Therapeutics, Cambridge, MA., Blanchard C; Intellia Therapeutics, Cambridge, MA., Burns S; Intellia Therapeutics, Cambridge, MA., Cromer MK; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA., Dahlman JE; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, 30332, USA., MacKenzie TC; Department of Surgery, University of California, San Francisco, CA, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, CA, USA.; The Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, CA, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 12. Date of Electronic Publication: 2025 May 12.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first